Table of Contents USA Neurotherapeutic Drugs Market Report 2012-2023 1 Neurotherapeutic Drugs Overview 1.1 Product Overview and Scope of Neurotherapeutic Drugs 1.2 Classification of Neurotherapeutic Drugs by Product Category 1.2.1 USA Neurotherapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Peripheral Nervous System Disorders (PNS) Disorder 1.2.4 Autonomous Nervous System (ANS) Disorder 1.2.5 Central Nervous System (CNS) Disorders 1.2.6 Other 1.3 USA Neurotherapeutic Drugs Market by Application/End Users 1.3.1 USA Neurotherapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 USA Neurotherapeutic Drugs Market by Region 1.4.1 USA Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Neurotherapeutic Drugs (2012-2023) 1.5.1 USA Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Neurotherapeutic Drugs 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Neurotherapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 BD Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis AG Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Johnson & Johnson Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pfizer Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sanofi-Aventis Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biogen Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 GlaxoSmithKline Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 AstraZeneca Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 AstraZeneca Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 AstraZeneca Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Merck 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Merck Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 4 USA Neurotherapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Neurotherapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 USA Neurotherapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Neurotherapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Neurotherapeutic Drugs Sales and Revenue by Type 4.2.1 USA Neurotherapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Neurotherapeutic Drugs Sales and Revenue by Application 4.3.1 USA Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Neurotherapeutic Drugs Sales (K Units) by Application 5 Northeast Neurotherapeutic Drugs (Sales, Revenue and Price) 5.1 Northeast Neurotherapeutic Drugs Sales and Value (2012-2017) 5.1.1 Northeast Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 5.3 Northeast Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 6 Midwest Neurotherapeutic Drugs (Sales, Revenue and Price) 6.1 Midwest Neurotherapeutic Drugs Sales and Value (2012-2017) 6.1.1 Midwest Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 6.3 Midwest Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 7 South Neurotherapeutic Drugs (Sales, Revenue and Price) 7.1 South Neurotherapeutic Drugs Sales and Value (2012-2017) 7.1.1 South Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 7.3 South Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 8 West Neurotherapeutic Drugs (Sales, Revenue and Price) 8.1 West Neurotherapeutic Drugs Sales and Value (2012-2017) 8.1.1 West Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 West Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 8.3 West Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Neurotherapeutic Drugs Market Forecast (2018-2023) 12.1 USA Neurotherapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) 12.2 USA Neurotherapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Neurotherapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Neurotherapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) 12.3.2 USA Neurotherapeutic Drugs Revenue Forecast by Type (2018-2023) 12.3.3 USA Neurotherapeutic Drugs Price Forecast by Type (2018-2023) 12.4 USA Neurotherapeutic Drugs Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Neurotherapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Neurotherapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Neurotherapeutic Drugs Table USA Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 Figure Peripheral Nervous System Disorders (PNS) Disorder Picture Figure Autonomous Nervous System (ANS) Disorder Picture Figure Central Nervous System (CNS) Disorders Picture Table USA Neurotherapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Neurotherapeutic Drugs by Applications in 2017 Figure Hosptical Examples Figure Drug Stores Examples Figure Other Examples Table USA Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure West Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure USA Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Neurotherapeutic Drugs Table Industry News List of Neurotherapeutic Drugs Figure Industry Chain Structure of Neurotherapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Neurotherapeutic Drugs Table Abbott Basic Information List Table Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Neurotherapeutic Drugs Volume in and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in and Its Application Share Table BD Basic Information List Table BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BD Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure BD Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure BD Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table BD Neurotherapeutic Drugs Volume in and Its Application Share Table BD Neurotherapeutic Drugs Volume in and Its Application Share Table BD Neurotherapeutic Drugs Volume in and Its Application Share Table Novartis AG Basic Information List Table Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Neurotherapeutic Drugs Volume in and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Neurotherapeutic Drugs Volume in and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in and Its Application Share Table Pfizer Basic Information List Table Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Neurotherapeutic Drugs Volume in and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in and Its Application Share Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Neurotherapeutic Drugs Volume in and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in and Its Application Share Table Biogen Basic Information List Table Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biogen Neurotherapeutic Drugs Volume in and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Neurotherapeutic Drugs Volume in and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Neurotherapeutic Drugs Volume in and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in and Its Application Share Table Company Merck Basic Information List Table Company Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Merck Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Merck Neurotherapeutic Drugs Sales USA Market Share (%) (2012-2017) Figure Company Merck Neurotherapeutic Drugs Revenue USA Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Merck Neurotherapeutic Drugs Volume in and Its Application Share Table Company Merck Neurotherapeutic Drugs Volume in and Its Application Share Table Company Merck Neurotherapeutic Drugs Volume in and Its Application Share Table USA Neurotherapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Neurotherapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Neurotherapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Neurotherapeutic Drugs Sales Share by Players/Manufacturers Table USA Neurotherapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Neurotherapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Neurotherapeutic Drugs Revenue Market Share (%) Players Figure 2017 USA Neurotherapeutic Drugs Revenue Market Share (%) Players Table USA Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Neurotherapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure USA Neurotherapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table USA Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Neurotherapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure USA Neurotherapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table USA Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table USA Neurotherapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure USA Neurotherapeutic Drugs Sales Market Share by Regions in 2017 Table USA Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Neurotherapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure USA Neurotherapeutic Drugs Revenue Market Share by Regions in 2017 Table USA Neurotherapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table USA Neurotherapeutic Drugs Sales Share (%) by Application (2012-2017) Figure USA Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure USA Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure Northeast Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Northeast Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Northeast Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Midwest Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Midwest Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Midwest Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Midwest Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table South Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table South Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table South Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure West Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure West Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table West Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table West Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure West Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table West Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table West Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure West Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) Table USA Neurotherapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure USA Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Neurotherapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Neurotherapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure USA Neurotherapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure Northeast Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Neurotherapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure USA Neurotherapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table USA Neurotherapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Neurotherapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table USA Neurotherapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table USA Neurotherapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure USA Neurotherapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck